589 related articles for article (PubMed ID: 7520084)
41. [Spatial structure of a Fab-fragment of a monoclonal antibody to human interleukin-2 in two crystalline forms at a resolution of 2.2 and 2.9 angstroms].
Fokin AV; Afonin PV; Mikhaĭlova IIu; Tsygannik IN; Mareeva TIu; Nesmeianov VA; Pangborn W; Lee N; Duax W; Siszak E; Pletnev VZ
Bioorg Khim; 2000 Aug; 26(8):571-8. PubMed ID: 11040993
[TBL] [Abstract][Full Text] [Related]
42. Crystallographic analysis of the interaction between cyclosporin A and the Fab fragment of a monoclonal antibody.
Vix O; Rees B; Thierry JC; Altschuh D
Proteins; 1993 Apr; 15(4):339-48. PubMed ID: 8460105
[TBL] [Abstract][Full Text] [Related]
43. Crystal parameters and molecular replacement of an anticholera toxin peptide complex.
Shoham M; Proctor P; Hughes D; Baldwin ET
Proteins; 1991; 11(3):218-22. PubMed ID: 1749774
[TBL] [Abstract][Full Text] [Related]
44. The third IgG-binding domain from streptococcal protein G. An analysis by X-ray crystallography of the structure alone and in a complex with Fab.
Derrick JP; Wigley DB
J Mol Biol; 1994 Nov; 243(5):906-18. PubMed ID: 7966308
[TBL] [Abstract][Full Text] [Related]
45. The crystal structure of the antibody N10-staphylococcal nuclease complex at 2.9 A resolution.
Bossart-Whitaker P; Chang CY; Novotny J; Benjamin DC; Sheriff S
J Mol Biol; 1995 Nov; 253(4):559-75. PubMed ID: 7473734
[TBL] [Abstract][Full Text] [Related]
46. Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallography.
Serrière J; Dugua JM; Bossus M; Verrier B; Haser R; Gouet P; Guillon C
J Mol Biol; 2011 Jan; 405(1):33-42. PubMed ID: 21035463
[TBL] [Abstract][Full Text] [Related]
47. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus.
Verdaguer N; Mateu MG; Bravo J; Domingo E; Fita I
J Mol Biol; 1996 Feb; 256(2):364-76. PubMed ID: 8594203
[TBL] [Abstract][Full Text] [Related]
48. Three-dimensional structure of a complex of antibody with influenza virus neuraminidase.
Colman PM; Laver WG; Varghese JN; Baker AT; Tulloch PA; Air GM; Webster RG
Nature; 1987 Mar 26-Apr 1; 326(6111):358-63. PubMed ID: 2436051
[TBL] [Abstract][Full Text] [Related]
49. Epitope analysis using kinetic measurements of antibody binding to synthetic peptides presenting single amino acid substitutions.
Zeder-Lutz G; Altschuh D; Denery-Papini S; Briand JP; Tribbick G; Van Regenmortel MH
J Mol Recognit; 1993 Jun; 6(2):71-9. PubMed ID: 7508237
[TBL] [Abstract][Full Text] [Related]
50. A synthetic peptide of influenza virus hemagglutinin as a model antigen and immunogen.
Jackson DC; Brown LE
Pept Res; 1991; 4(3):114-24. PubMed ID: 1823182
[TBL] [Abstract][Full Text] [Related]
51. Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding.
Bhat TN; Bentley GA; Fischmann TO; Boulot G; Poljak RJ
Nature; 1990 Oct; 347(6292):483-5. PubMed ID: 2215663
[TBL] [Abstract][Full Text] [Related]
52. Three-dimensional structures of the Fab fragment of murine N1G9 antibody from the primary immune response and of its complex with (4-hydroxy-3-nitrophenyl)acetate.
Mizutani R; Miura K; Nakayama T; Shimada I; Arata Y; Satow Y
J Mol Biol; 1995 Nov; 254(2):208-22. PubMed ID: 7490744
[TBL] [Abstract][Full Text] [Related]
53. Structural evidence for induced fit as a mechanism for antibody-antigen recognition.
Rini JM; Schulze-Gahmen U; Wilson IA
Science; 1992 Feb; 255(5047):959-65. PubMed ID: 1546293
[TBL] [Abstract][Full Text] [Related]
54. [Various approaches to designing the functionally active determinants as illustrated by the influenza virus A(H3N2) hemagglutinin].
Shibnev VA; Sharetskiĭ AN; Valiev RV; Khalikov ShKh
Bioorg Khim; 1990 Jul; 16(7):926-32. PubMed ID: 1700716
[TBL] [Abstract][Full Text] [Related]
55. Effect of variations in peptide sequence on anti-human milk fat globule membrane antibody reactions.
Xing PX; Reynolds K; Pietersz GA; McKenzie IF
Immunology; 1991 Feb; 72(2):304-11. PubMed ID: 1707852
[TBL] [Abstract][Full Text] [Related]
56. Analysis of antibody-antigen and antibody-anti-(idiotypic antibody) cross-reactivity using synthetic peptide probes.
McInerney TL; Brown LE; Sutton VR; Jackson DC
Mol Immunol; 1994 Mar; 31(4):289-99. PubMed ID: 7511212
[TBL] [Abstract][Full Text] [Related]
57. The three-dimensional structure of an intact monoclonal antibody for canine lymphoma.
Harris LJ; Larson SB; Hasel KW; Day J; Greenwood A; McPherson A
Nature; 1992 Nov; 360(6402):369-72. PubMed ID: 1448155
[TBL] [Abstract][Full Text] [Related]
58. A multiply substituted G-H loop from foot-and-mouth disease virus in complex with a neutralizing antibody: a role for water molecules.
Ochoa WF; Kalko SG; Mateu MG; Gomes P; Andreu D; Domingo E; Fita I; Verdaguer N
J Gen Virol; 2000 Jun; 81(Pt 6):1495-505. PubMed ID: 10811933
[TBL] [Abstract][Full Text] [Related]
59. Structural mechanism of the antigen recognition by the L1 cell adhesion molecule antibody A10-A3.
Wei CH; Lee ES; Jeon JY; Heo YS; Kim SJ; Jeon YH; Kim KH; Hong HJ; Ryu SE
FEBS Lett; 2011 Jan; 585(1):153-8. PubMed ID: 21094640
[TBL] [Abstract][Full Text] [Related]
60. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.
Xu R; Ekiert DC; Krause JC; Hai R; Crowe JE; Wilson IA
Science; 2010 Apr; 328(5976):357-60. PubMed ID: 20339031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
